Wenquan Liang

Chinese PLA General Hospital, Hainan 301 Hospital

Papers

6

Total Citations

75

H-Index

5

About

Dr. Wenquan Liang is a pioneering surgeon-scientist advancing the frontiers of minimally invasive gastric cancer surgery. His research focuses on robotic and laparoscopic gastrectomy, with a particular emphasis on single-port (SP) robotic techniques and function-preserving approaches for early and advanced gastric cancer. Dr. Liang’s major contributions include demonstrating the safety and feasibility of the da Vinci SP platform for total gastrectomy in advanced gastric cancer—a landmark study that has garnered 22 citations. He has also provided critical comparative evidence on robotic versus laparoscopic proximal gastrectomy for early upper gastric cancer, highlighting superior oncological and nutritional outcomes. His work extends to multi-institutional randomized trials comparing totally robotic and laparoscopic distal gastrectomy, with a focus on short-term outcomes and quality of life. Notably, his five-year cohort study offers long-term comparative data on robotic and laparoscopic gastrectomy, reinforcing the durability of robotic approaches. With over 75 cumulative citations across his most-cited works, Dr. Liang is shaping the evidence base for robotic gastrectomy, pushing toward less invasive, more precise surgical options that improve patient recovery and survival.

Research Focus

Key Achievements

5
H-Index
6
Papers
75
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Can a single-port robot be safely used for robotic total gastrectomy for advanced gastric cancer? First experience using the da Vinci SP platform
22 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 33
🏛 Institutions: Chinese PLA General Hospital, Hainan 301 Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago